68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate

被引：8
|
作者：
Qiu, Shuang [1 ]
Dong, Aisheng [1 ]
Zhu, Yan [2 ]
Zuo, Changjing [1 ]
机构：
[1] Navy Med Univ, Changhai Hosp, Dept Nucl Med, 168 Changhai Rd, Shanghai 200433, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期
关键词：
prostatic ductal adenocarcinoma; PSMA; FDG; PET/CT;
D O I：
10.1097/RLU.0000000000004230
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Prostatic ductal adenocarcinoma is an uncommon variant of prostatic carcinoma with aggressive behavior and worse prognosis. We describe Ga-68-PSMA-11 and FDG PET/CT findings in a case of prostatic ductal adenocarcinoma with pelvic lymph node metastases. The majority of the prostate tumor and all the metastatic lesions showed no significant PSMA uptake but intense FDG uptake. The role of PSMA and FDG PET in the management of prostatic ductal adenocarcinoma needs to be investigated in a large number of patients.
引用
收藏
页码：836 / 838
页数：3
相关论文
共 50 条
  • [31] 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
    Gundogan, Cihan
    Ergul, Nurhan
    Cakir, Mehmet Semih
    Kilickesmez, Ozgur
    Gursu, Riza Umar
    Aksoy, Tamer
    Cermik, Tevfik Fikret
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 79 - 85
  • [32] Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
    Calais, Jeremie
    Fendler, Wolfgang P.
    Herrmann, Ken
    Eiber, Matthias
    Ceci, Francesco
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 789 - 794
  • [33] 68Ga-PSMA-11 PET/CT in Cherry Hemangiomas
    Betech-Antar, Vicky
    Urtasun-Iriarte, Cesar
    Rosales, Juan J.
    Barrio-Piqueras, Miguel
    Rodriguez-Fraile, Macarena
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : e591 - e592
  • [34] 18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer?
    Laura Evangelista
    Lea Cuppari
    Clinical and Translational Imaging, 2018, 6 : 329 - 330
  • [35] 68Ga-PSMA-11 PET/CT and ADT Monitoring
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 22N - 22N
  • [36] 18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer?
    Evangelista, Laura
    Cuppari, Lea
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (04) : 329 - 330
  • [37] Metastatic prostate adenocarcinoma with neuroendocrine differentiation on 18F-FDG PET/CT, 68Ga-PSMA PET/CT and 68Ga-DOTA TATE PET/CT with injected ultra-low-activity
    Zhang, Y.
    He, Y.
    Yu, H.
    Shi, H.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2022, 46 (5-6): : 224 - 226
  • [38] 68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
    Sachpekidis, Christos
    Kopka, Klaus
    Eder, Matthias
    Hadaschik, Boris A.
    Freitag, Martin T.
    Pan, Leyun
    Haberkorn, Uwe
    Dimitrakopoulou-Strauss, Antonia
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (11) : E473 - E479
  • [39] Use of 68Ga-PSMA-11 and 18F-FDG PET-CT Dual-Tracer to Differentiate Between Lymph Node Metastases and Ganglia
    Shi, Yiping
    Xu, Lian
    Zhu, Yinjie
    Wang, Yining
    Chen, Ruohua
    Liu, Jianjun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] 68Ga-PSMA-11 PET/CT in the evaluation of bone metastases in prostate cancer
    Sachpekidis, C.
    Baeumer, P.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S402 - S403
12345